Pharmacy alumna leaves scientific legacy of perseverance and dedication
The University of Cincinnati James L. Winkle College of Pharmacy mourns the loss of Samar Alanazi, a dedicated researcher who faced both personal and scientific battles with unwavering strength.
Alanazi's journey in the lab of UC's Joan Garrett, PhD, exemplifies resilience, determination and an enduring commitment to advancing scientific knowledge, even in the face of personal adversity.
Alanazi joined the Garrett lab in 2017, embarking on a doctoral research journey focused on identifying HER3 binding partners in HER2+ breast cancers. Collaborating with Dr. Rosalin Mishra, PhD, she made a groundbreaking discovery, pinpointing non-muscle myosin IIa (NMIIA) as a HER3 binding partner. Furthermore, she revealed that NMIIA levels increased upon HER2 inhibition, opening new avenues for understanding breast cancer pathways.
Despite her own battle with cancer, Alanazi tirelessly worked in the lab, confirming her findings and generating new cell lines. Her dedication culminated in the publication of her first-author work in the journal PLOS One in April 2023, and she defended her doctoral thesis remotely while undergoing cancer treatment in May 2023. Tragically, Alanazi passed away in July 2023.
Alanazi's impact lives on through her research, as the Garrett lab now co-targets the NMIIA pathway and HER2 in HER2+ breast cancer. Her legacy inspires fellow researchers to persist in the pursuit of knowledge.
Samar Alanazi and her colleagues in Joan Garrett's lab made groundbreaking breast cancer research discoveries that continue to advance knowledge in the field. Photo provided.
Alanazi's scientific journey ran parallel to her personal battle against a rare type of breast cancer, phyllodes, diagnosed in 2014, just two months after giving birth to twins. For years, she received treatment at Cincinnati Children’s Hospital Medical Center, never complaining and working to the best of her ability. Her strength and determination serve as a testament to her character, leaving an indelible mark on those who knew her.
In her own words in the acknowledgment section of her thesis, Alanazi reflected on the dual battles she faced, expressing confidence in the enduring impact of her scientific contributions.
"While I may not lay claim to victory in the battle against cancer within my body, the scientific journey at Dr. Garrett's lab endures, even beyond my passing," she wrote. "I am confident that this perpetual battle will ultimately emerge victorious, and science will prevail in the end. I urge everyone who encounters this message or hears my story to persist in their battles on every front."
Alanazi expressed deep gratitude to those who played pivotal roles in her journey, including Garrett, her mentor, her homeland of Saudi Arabia and her husband, children and extended family.
Featured photo at top of Samar Alanazi, far left, and colleagues in a College of Pharmacy laboratory. Photo provided.
Alyssa McKinney
Marketing Coordinator, James L. Winkle College of Pharmacy
Related Stories
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.
These teeny spiders are social media stars
August 28, 2026
The New York Times turned to a University of Cincinnati professor to explain the appeal of jumping spiders on social media.
On-site training in Speech & Hearing Clinic sets UC’s programs apart
August 27, 2026
At the University of Cincinnati’s Speech & Hearing Clinic, Doctor of Audiology and Speech-Language Pathology graduate students gain real-world experience while providing free speech and hearing services to the community.